Cancer metabolism: new validated targets for drug discovery.
about
miR-34: from bench to bedsideThe altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transportersROS homeostasis and metabolism: a critical liaison for cancer therapyCopper activates HIF-1α/GPER/VEGF signalling in cancer cellsMicroenvironmental regulation of therapeutic response in cancerMarine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.The nutritional phenome of EMT-induced cancer stem-like cellsCancer genomic research at the crossroads: realizing the changing genetic landscape as intratumoral spatial and temporal heterogeneity becomes a confounding factor.TAp73 promotes anti-senescence-anabolism not proliferation.Bioinformatics analysis of the serine and glycine pathway in cancer cellsPeritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.Thyroid Cancer Metabolism: A ReviewLong-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinomaMitochondrial oxidative stress is the Achille's heel of melanoma cells resistant to Braf-mutant inhibitor.SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma.JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention.Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.GATA2 as a potential metastasis-driving gene in prostate cancer.Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma.A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer.Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.Chromosomal instability causes sensitivity to metabolic stress.Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer
P2860
Q26822928-6B553FB8-01E3-4693-ABC6-CDFE897D00B4Q28072360-B68B09C9-810A-4451-95DC-70611CE3A0D9Q28080316-F649CD6A-23C8-4ED8-8CBA-A0690EC18430Q28601324-08F264A3-B8D1-449C-9AEE-13D65DA724F6Q33654609-0C22E91F-9912-4A2B-9D1D-73523E64EE1BQ33834080-9168E510-4BFE-4F66-A3FC-749695E1DBACQ34100815-A99B88CD-E631-4ECE-A411-B7C0A206E6EAQ34537690-EC6E283F-D160-408D-91F5-AE9263D72E66Q34774270-6FA5005E-D4BC-4332-8C8C-B05FA2FDC02FQ34956789-B3D81BB4-51D4-40DF-A25D-5C7DB083726FQ35955331-F16586B8-15EA-417F-B6DA-745BF68ADD87Q36419289-5E5B0F47-24BF-49F6-B62A-9E3F6D3732E7Q36920538-FBF8FBF0-9B6A-4243-B2A0-8F55C5EB7980Q37225266-75564D45-40BD-4170-B6BC-2BF039EA04C5Q37420174-677B5791-A708-43E8-B084-B5739B8E5DFDQ37457747-4CC67C8E-8BF7-4D6B-8A92-E72EB9E23D32Q37705086-BCA685A4-BB38-4C69-99AE-7A7FF983FDCBQ38323902-4309183D-2D03-4E9C-86A7-1FEF0712A1BCQ38457785-7DFC4D34-144D-4F3B-80AC-C0F50C5C6CBCQ39040965-58291DB8-2B30-498C-8A95-862181955E79Q39124486-9756D6DF-B6F5-4FBB-BAC9-3BE9EC9C8BA7Q39247899-3BD3E05F-CE6C-4B56-B78B-C18BB10ED101Q46821301-6090FDF8-374B-4F5E-96AF-BA8F661E9396Q47162272-1A80B3B3-2E2F-45E7-BD4D-04787CAA1F2FQ58723357-FDC3BEB8-7992-41A7-AF2C-73296BDE41BA
P2860
Cancer metabolism: new validated targets for drug discovery.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cancer metabolism: new validated targets for drug discovery.
@en
Cancer metabolism: new validated targets for drug discovery.
@nl
type
label
Cancer metabolism: new validated targets for drug discovery.
@en
Cancer metabolism: new validated targets for drug discovery.
@nl
prefLabel
Cancer metabolism: new validated targets for drug discovery.
@en
Cancer metabolism: new validated targets for drug discovery.
@nl
P2860
P356
P1433
P1476
Cancer metabolism: new validated targets for drug discovery.
@en
P2093
Ubaldo E Martinez-Outschoorn
P2860
P304
P356
10.18632/ONCOTARGET.1182
P407
P577
2013-08-01T00:00:00Z